Biechele Royce Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-105,677
| Closed | -$6.76M | – | 66 |
|
|
2023
Q2 | $6.76M | Sell |
105,677
-8,686
| -8% | -$556K | 2.35% | 18 |
|
|
2023
Q1 | $7.93M | Sell |
114,363
-5,109
| -4% | -$354K | 2.95% | 16 |
|
|
2022
Q4 | $8.6M | Sell |
119,472
-5,712
| -5% | -$411K | 3.51% | 15 |
|
|
2022
Q3 | $8.9M | Sell |
125,184
-10,619
| -8% | -$755K | 4.19% | 8 |
|
|
2022
Q2 | $10.5M | Sell |
135,803
-5,804
| -4% | -$447K | 4.65% | 5 |
|
|
2022
Q1 | $10.3M | Sell |
141,607
-1,747
| -1% | -$128K | 4.12% | 10 |
|
|
2021
Q4 | $8.94M | Buy |
143,354
+5,715
| +4% | +$356K | 3.58% | 12 |
|
|
2021
Q3 | $8.14M | Buy |
137,639
+3,674
| +3% | +$217K | 3.6% | 12 |
|
|
2021
Q2 | $8.95M | Buy |
133,965
+5,155
| +4% | +$344K | 3.88% | 11 |
|
|
2021
Q1 | $8.13M | Buy |
128,810
+74,600
| +138% | +$4.71M | 4.09% | 11 |
|
|
2020
Q4 | $3.36M | Sell |
54,210
-271
| -0.5% | -$16.8K | 1.9% | 20 |
|
|
2020
Q3 | $3.29M | Sell |
54,481
-1,586
| -3% | -$95.6K | 2.07% | 22 |
|
|
2020
Q2 | $3.3M | Sell |
56,067
-594
| -1% | -$34.9K | 2.08% | 20 |
|
|
2020
Q1 | $3.16M | Sell |
56,661
-3,141
| -5% | -$175K | 2.43% | 19 |
|
|
2019
Q4 | $3.84M | Sell |
59,802
-1,165
| -2% | -$74.8K | 2.31% | 20 |
|
|
2019
Q3 | $3.09M | Buy |
60,967
+2,952
| +5% | +$150K | 2.04% | 22 |
|
|
2019
Q2 | $2.63M | Buy |
58,015
+3,114
| +6% | +$141K | 1.74% | 22 |
|
|
2019
Q1 | $2.62M | Buy |
54,901
+2,477
| +5% | +$118K | 1.7% | 24 |
|
|
2018
Q4 | $2.73M | Sell |
52,424
-593
| -1% | -$30.8K | 1.96% | 22 |
|
|
2018
Q3 | $3.29M | Sell |
53,017
-45,446
| -46% | -$2.82M | 2.06% | 21 |
|
|
2018
Q2 | $5.45M | Buy |
98,463
+7,704
| +8% | +$426K | 3.65% | 8 |
|
|
2018
Q1 | $5.74M | Buy |
90,759
+935
| +1% | +$59.1K | 4.01% | 8 |
|
|
2017
Q4 | $5.5M | Buy |
+89,824
| New | +$5.5M | 3.74% | 9 |
|